WHAT: "Practical Aspects to Improving Outcomes in Schizophrenia"
Learn about practical treatment options and techniques for people with schizophrenia.
WHEN: October 5, 1998 6 a.m. to 8 a.m. PST
WHERE: The American Psychiatric Association's Institute on Psychiatric Services Annual Meeting
Westin Bonaventure Hotel San Francisco Ballroom, Level 2
404 South Figueroa (entrance on Flower between Fourth and Fifth)
Los Angeles, CA
213-624-1000
WHO: "Relapse Prevention: How to Get More from Medications,"
Peter Weiden, M.D.
"How to Make Psychoeducation Really Effective,"
Patricia Scheifler, M.S.W.
"Medication Side Effects and Quality of Life: Has the
Paradigm Changed?"
Sharon Dott, M.D.
"Quality of Life: What do Clients Tell Us?"
Ronald Diamond, M.D.
-- This symposium is sponsored by the American Psychiatric Association and supported by an unrestricted grant from Zeneca Pharmaceuticals, manufacturer of SEROQUEL(r) (quetiapine fumarate) tablets, an atypical antipsychotic indicated for the management of the manifestations of psychotic disorders, including schizophrenia.
-- For more information or to schedule an interview, contact
Robert Couter at 312-329-7514 or [email protected] or
Rachel Bloom at 302-886-7858 or [email protected]
Symposium Presenters
Ronald Diamond, M.D.
Ronald Diamond, M.D., is a professor in the Department of Psychiatry at the University of Wisconsin. He also serves as medical director of the Mental Health Center of Dane County in Wisconsin and as director of the Acute Psychiatric Service at the University of Wisconsin Crisis Service. He has been involved in the community-based treatment of persons with severe and persistent mental illness for more than 20 years, with a special interest in measuring and improving quality of life for persons with schizophrenia.
Sharon G. Dott, M.D.
Sharon Gail Dott, M.D., is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical Branch in Galveston. She also serves as medical director of the Crisis Resolution Unit and Intensive Treatment Programs of the Gulf Coast Center in Texas. Dr. Dott's areas of expertise include quality of life research for the mentally ill and safety and efficacy of schizophrenia treatments.
Patricia Scheifler, M.S.W.
Patricia Scheifler, M.S.W., director of the Partnership for Recovery in Birmingham, Ala., specializes in providing, developing and enhancing services for people who are recovering from serious mental illness. She lectures widely around the United States and conducts workshops for people suffering from severe mental illness and their families.
Peter J. Weiden, M.D.
Peter J. Weiden, M.D., is director of the Neurobiological Disorders Service of St. Luke's-Roosevelt Hospital Center in New York and is an associate professor of clinical psychiatry at Columbia University. He also is a fellow in psychiatric epidemiology at the School of Public Health at Columbia University. Dr. Weiden has been a clinical investigator for several of the atypical antipsychotics and currently is researching the impact these agents may have on medication compliance and relapse under "real world" conditions.
# # #
RSS